Targeted Muscle Reinnervation Does Not Increase the Risk of Postsurgical Complication or Overall Cost
Background:. Targeted muscle reinnervation (TMR) has shown promise in reducing postsurgical limb pain in amputees. However, there has been little evidence on the increased risk of complications and cost as compared with traditional amputations. This study was designed to assess the rate of complicat...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2022-08-01
|
| Series: | Plastic and Reconstructive Surgery, Global Open |
| Online Access: | http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000004488 |
| _version_ | 1828355575309664256 |
|---|---|
| author | Sorka T. Deeyor, BS Haroon M. Kisana, MS Clayton H. Hui, BSE Chad Stecher, PhD Joshua W. Hustedt, MD, MHS |
| author_facet | Sorka T. Deeyor, BS Haroon M. Kisana, MS Clayton H. Hui, BSE Chad Stecher, PhD Joshua W. Hustedt, MD, MHS |
| author_sort | Sorka T. Deeyor, BS |
| collection | DOAJ |
| description | Background:. Targeted muscle reinnervation (TMR) has shown promise in reducing postsurgical limb pain in amputees. However, there has been little evidence on the increased risk of complications and cost as compared with traditional amputations. This study was designed to assess the rate of complications and healthcare costs between those treated with TMR and traditional amputations.
Methods:. Patients undergoing amputation were selected from the PearlDiver Mariner dataset and categorized into one of two treatment groups depending on the use of TMR versus traditional amputation. Rates of postsurgical complications and overall healthcare costs were compared between the two groups, while controlling for differences in patient demographics and comorbidities.
Results:. One hundred sixteen TMR procedures and 76,412 traditional amputations were included in the study. The rate of complications did not differ between groups, with a complication rate of 77% in the TMR and 87% in the traditional amputation groups. Overall healthcare costs also did not differ 1 year after surgery, with an average cost of $32,632 in the TMR group and $36,219 in the traditional amputation group.
Conclusions:. Amputees experience high rates of postsurgical complications, morbidity, and mortality. However, there is no increased risk of complications or cost with the use of TMR. TMR has the potential benefits of reducing overall postsurgical pain and reestablishing activities of daily living. Although TMR is more expensive up front, it may reduce the overall healthcare costs by reducing the need for subsequent care. Further work is needed in large, randomized trials to examine these findings. |
| first_indexed | 2024-04-14T02:44:35Z |
| format | Article |
| id | doaj.art-6205947d50d84b199c1db5a8d0439413 |
| institution | Directory Open Access Journal |
| issn | 2169-7574 |
| language | English |
| last_indexed | 2024-04-14T02:44:35Z |
| publishDate | 2022-08-01 |
| publisher | Wolters Kluwer |
| record_format | Article |
| series | Plastic and Reconstructive Surgery, Global Open |
| spelling | doaj.art-6205947d50d84b199c1db5a8d04394132022-12-22T02:16:37ZengWolters KluwerPlastic and Reconstructive Surgery, Global Open2169-75742022-08-01108e448810.1097/GOX.0000000000004488202208000-00032Targeted Muscle Reinnervation Does Not Increase the Risk of Postsurgical Complication or Overall CostSorka T. Deeyor, BS0Haroon M. Kisana, MS1Clayton H. Hui, BSE2Chad Stecher, PhD3Joshua W. Hustedt, MD, MHS4From the * Department of Orthopedics, University of Arizona College of Medicine–Phoenix, Phoenix, Ariz.From the * Department of Orthopedics, University of Arizona College of Medicine–Phoenix, Phoenix, Ariz.From the * Department of Orthopedics, University of Arizona College of Medicine–Phoenix, Phoenix, Ariz.† College of Health Solutions, Arizona State University, Tempe, Ariz.From the * Department of Orthopedics, University of Arizona College of Medicine–Phoenix, Phoenix, Ariz.Background:. Targeted muscle reinnervation (TMR) has shown promise in reducing postsurgical limb pain in amputees. However, there has been little evidence on the increased risk of complications and cost as compared with traditional amputations. This study was designed to assess the rate of complications and healthcare costs between those treated with TMR and traditional amputations. Methods:. Patients undergoing amputation were selected from the PearlDiver Mariner dataset and categorized into one of two treatment groups depending on the use of TMR versus traditional amputation. Rates of postsurgical complications and overall healthcare costs were compared between the two groups, while controlling for differences in patient demographics and comorbidities. Results:. One hundred sixteen TMR procedures and 76,412 traditional amputations were included in the study. The rate of complications did not differ between groups, with a complication rate of 77% in the TMR and 87% in the traditional amputation groups. Overall healthcare costs also did not differ 1 year after surgery, with an average cost of $32,632 in the TMR group and $36,219 in the traditional amputation group. Conclusions:. Amputees experience high rates of postsurgical complications, morbidity, and mortality. However, there is no increased risk of complications or cost with the use of TMR. TMR has the potential benefits of reducing overall postsurgical pain and reestablishing activities of daily living. Although TMR is more expensive up front, it may reduce the overall healthcare costs by reducing the need for subsequent care. Further work is needed in large, randomized trials to examine these findings.http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000004488 |
| spellingShingle | Sorka T. Deeyor, BS Haroon M. Kisana, MS Clayton H. Hui, BSE Chad Stecher, PhD Joshua W. Hustedt, MD, MHS Targeted Muscle Reinnervation Does Not Increase the Risk of Postsurgical Complication or Overall Cost Plastic and Reconstructive Surgery, Global Open |
| title | Targeted Muscle Reinnervation Does Not Increase the Risk of Postsurgical Complication or Overall Cost |
| title_full | Targeted Muscle Reinnervation Does Not Increase the Risk of Postsurgical Complication or Overall Cost |
| title_fullStr | Targeted Muscle Reinnervation Does Not Increase the Risk of Postsurgical Complication or Overall Cost |
| title_full_unstemmed | Targeted Muscle Reinnervation Does Not Increase the Risk of Postsurgical Complication or Overall Cost |
| title_short | Targeted Muscle Reinnervation Does Not Increase the Risk of Postsurgical Complication or Overall Cost |
| title_sort | targeted muscle reinnervation does not increase the risk of postsurgical complication or overall cost |
| url | http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000004488 |
| work_keys_str_mv | AT sorkatdeeyorbs targetedmusclereinnervationdoesnotincreasetheriskofpostsurgicalcomplicationoroverallcost AT haroonmkisanams targetedmusclereinnervationdoesnotincreasetheriskofpostsurgicalcomplicationoroverallcost AT claytonhhuibse targetedmusclereinnervationdoesnotincreasetheriskofpostsurgicalcomplicationoroverallcost AT chadstecherphd targetedmusclereinnervationdoesnotincreasetheriskofpostsurgicalcomplicationoroverallcost AT joshuawhustedtmdmhs targetedmusclereinnervationdoesnotincreasetheriskofpostsurgicalcomplicationoroverallcost |